Insider Trading History of Cline Darren S

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Cline Darren S since 2015. This trader's CIK number is 1633639. At the time of last reporting, Cline Darren S was the Director of Pyxis Oncology, Inc.. (stock ticker symbol PYXS). Also see all insider trading activities at Pyxis Oncology, Inc..

Note that in the past Cline Darren S also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Gw Pharmaceuticals Plc (GWPH) by Cline Darren S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 GWPH 0 $0 0 $0 7,356 $7

Yearly summary of insider trading at Pyxis Oncology, Inc. (PYXS) by Cline Darren S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 PYXS 10,000 $93,890 0 $0 0 $0

Yearly summary of insider trading at Seagen Inc. (SGEN) by Cline Darren S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 SGEN 0 $0 41,005 $2,576,291 19,086 $368,685
2017 SGEN 0 $0 20,381 $1,039,190 18,955 $324,537
2016 SGEN 0 $0 22,768 $1,204,362 20,028 $399,607
2015 SGEN 0 $0 15,500 $647,177 0 $0


Insider trading activities at 3 companies by Cline Darren S:

1. Gw Pharmaceuticals Plc (GWPH)

2. Pyxis Oncology, Inc. (PYXS)

3. Seagen Inc. (SGEN)

Table 1. Insider trading of Gw Pharmaceuticals Plc (GWPH) by Cline Darren S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-05-28 GWPH Option Ex 7,356 .00 7

Table 2. Insider trading of Pyxis Oncology, Inc. (PYXS) by Cline Darren S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-12-08 PYXS Buy 10,000 9.39 93,890

Table 3. Insider trading of Seagen Inc. (SGEN) by Cline Darren S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-11-29 SGEN Sale 7,000 62.88 440,160
2018-11-21 SGEN Sale 4,167 56.69 236,206
2018-08-27 SGEN Sale 4,784 74.23 355,125
2018-06-12 SGEN Sale 12,054 68.99 831,581
2018-06-12 SGEN Option Ex 10,086 22.34 225,270
2018-05-09 SGEN Sale 9,000 55.33 497,979
2018-05-09 SGEN Option Ex 9,000 15.94 143,415
2018-05-03 SGEN Sale 4,000 53.81 215,240
2017-09-06 SGEN Option Ex 10,048 15.94 160,114
2017-09-06 SGEN Sale 5,024 51.94 260,966
2017-08-31 SGEN Option Ex 2,907 18.46 53,663
2017-08-31 SGEN Sale 7,569 52.51 397,478
2017-08-28 SGEN Sale 1,788 47.90 85,636
2017-08-07 SGEN Option Ex 6,000 18.46 110,760
2017-08-07 SGEN Sale 6,000 49.19 295,110
2016-12-16 SGEN Option Ex 3,100 16.41 50,871
2016-12-13 SGEN Sale 10,000 63.80 638,010
2016-12-13 SGEN Option Ex 12,761 22.28 284,315
2016-09-09 SGEN Option Ex 4,167 15.46 64,421
2016-09-06 SGEN Sale 5,397 46.01 248,326
2016-08-22 SGEN Sale 1,774 46.59 82,652
2015-08-20 SGEN Sale 2,231 42.02 93,757
2016-06-02 SGEN Sale 3,366 42.07 141,617
2015-11-11 SGEN Sale 5,769 45.68 263,545
2015-08-20 SGEN Sale 2,231 42.02 93,757
2015-03-13 SGEN Sale 7,500 38.65 289,875

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cline Darren S (Director of Pyxis Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.